EXEL
Exelixis (EXEL)
$43
About Exelixis (EXEL)
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Details
Daily high
$36.90
Daily low
$35.91
Price at open
$36.44
52 Week High
$37.59
52 Week Low
$20.02
Market cap
10.3B
Dividend yield
0.00%
Volume
2.2M
Avg. volume
2.2M
P/E ratio
23.07
Exelixis News
Details
Daily high
$36.90
Daily low
$35.91
Price at open
$36.44
52 Week High
$37.59
52 Week Low
$20.02
Market cap
10.3B
Dividend yield
0.00%
Volume
2.2M
Avg. volume
2.2M
P/E ratio
23.07